Electromed
ELMD
About: Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Employees: 180
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
78% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 18
2.59% more ownership
Funds ownership: 43.35% [Q1] → 45.94% (+2.59%) [Q2]
4% less capital invested
Capital invested by funds: $88.5M [Q1] → $84.7M (-$3.72M) [Q2]
12% less funds holding
Funds holding: 94 [Q1] → 83 (-11) [Q2]
35% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 31
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
|
Roth Capital
Kyle Bauser
|
$35
|
Buy
Maintained
|
27 Aug 2025 |
|
Lake Street
Benjamin Haynor
|
$36
|
Buy
Assumed
|
27 Aug 2025 |
Financial journalist opinion
Based on 6 articles about ELMD published over the past 30 days
